Pharmacologically inhibiting CTGF effectively dismantles this mutualistic interaction between cancer cells and α‐SMA+ CAFs, thereby suppressing peritoneal metastasis and enhancing patient survival rates. This evidence concerns the gene ACTA1 and cancer.